These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25336414)

  • 21. Orientation to determine quality attributes of flavoring excipients containing volatile molecules.
    Kiene FE; Pein M; Thommes M
    J Pharm Biomed Anal; 2015 Jun; 110():20-6. PubMed ID: 25796980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The evolution and challenges for the international harmonization of the regulation of pharmaceutical excipients in Taiwan.
    Chang LC; Kang JJ; Gau CS
    Regul Toxicol Pharmacol; 2015 Dec; 73(3):947-52. PubMed ID: 26387930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low powder mass filling of dry powder inhalation formulations.
    Eskandar F; Lejeune M; Edge S
    Drug Dev Ind Pharm; 2011 Jan; 37(1):24-32. PubMed ID: 20738180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microstructural characterization of carrier-based dry powder inhalation excipients: Insights and guidance.
    Elsayed MMA
    Int J Pharm; 2019 Sep; 568():118482. PubMed ID: 31260786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding.
    Hyde TD
    Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Entrainment of lactose inhalation powders: a study using laser diffraction.
    Watling CP; Elliott JA; Cameron RE
    Eur J Pharm Sci; 2010 Jul; 40(4):352-8. PubMed ID: 20417708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elemental Impurities in Pharmaceutical Excipients.
    Li G; Schoneker D; Ulman KL; Sturm JJ; Thackery LM; Kauffman JF
    J Pharm Sci; 2015 Dec; 104(12):4197-4206. PubMed ID: 26398581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishing powder-handling workflow practices and standard operating procedures: compounding pharmacy and safety.
    Prince B; Lundevall J
    Int J Pharm Compd; 2014; 18(3):222-6. PubMed ID: 25306770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug.
    Alyami H; Dahmash E; Bowen J; Mohammed AR
    PLoS One; 2017; 12(6):e0178772. PubMed ID: 28609454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of Methods for Recovering Endotoxins from Surfaces and from Air in Production Environment of Injectable Drugs.
    Fiammetta F; Carducci A; Davini G; Macchia M; Bertini S; Vecchiani S; Ceccanti S
    PDA J Pharm Sci Technol; 2017; 71(6):502-510. PubMed ID: 28819048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. July-August 2020 Issue.
    Levy R
    PDA J Pharm Sci Technol; 2020; 74(4):367. PubMed ID: 32737241
    [No Abstract]   [Full Text] [Related]  

  • 33. Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: Carrier porosity and fine particle content.
    Shalash AO; Molokhia AM; Elsayed MM
    Eur J Pharm Biopharm; 2015 Oct; 96():291-303. PubMed ID: 26275831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmaceutical quality by design: product and process development, understanding, and control.
    Yu LX
    Pharm Res; 2008 Apr; 25(4):781-91. PubMed ID: 18185986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematical approach of formulation and process development using roller compaction.
    Teng Y; Qiu Z; Wen H
    Eur J Pharm Biopharm; 2009 Oct; 73(2):219-29. PubMed ID: 19406236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification of pharmaceutical excipients with supercritical fluid extraction.
    Ashraf-Khorassani M; Taylor LT; Waterman KC; Narayan P; Brannegan DR; Reid GL
    Pharm Dev Technol; 2005; 10(4):507-16. PubMed ID: 16370180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opportunities and challenges of real-time release testing in biopharmaceutical manufacturing.
    Jiang M; Severson KA; Love JC; Madden H; Swann P; Zang L; Braatz RD
    Biotechnol Bioeng; 2017 Nov; 114(11):2445-2456. PubMed ID: 28710854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymer coating of carrier excipients modify aerosol performance of adhered drugs used in dry powder inhalation therapy.
    Traini D; Scalia S; Adi H; Marangoni E; Young PM
    Int J Pharm; 2012 Nov; 438(1-2):150-9. PubMed ID: 22964399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dry powders for oral inhalation free of lactose carrier particles.
    Healy AM; Amaro MI; Paluch KJ; Tajber L
    Adv Drug Deliv Rev; 2014 Aug; 75():32-52. PubMed ID: 24735676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence against a bacterial endotoxin masking effect in biologic drug products by limulus amebocyte lysate detection.
    Bolden JS; Claerbout ME; Miner MK; Murphy MA; Smith KR; Warburton RE
    PDA J Pharm Sci Technol; 2014; 68(5):472-7. PubMed ID: 25336418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.